WeVote
Log In

Bill

Bill

SF 1499

Limitations modification on optometrists prescribing and administering drugs

2025-2026 Regular Session Introduced by Jim Abeler and 3 co-sponsors

SF 1499 would loosen current limits on optometrists’ ability to prescribe and administer drugs, expanding patient access to medications in Minnesota.

Author stricken Koran
#drugsandmedicine #healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · SF 1499

Summary of SF 1499: Limitations modification on optometrists prescribing and administering drugs

Overview

SF 1499 proposes changes to the statutory limitations governing optometrists' authority to prescribe and administer drugs. The available information identifies the bill’s broad objective as modifying restrictions on optometrists’ prescribing and drug administration powers in Minnesota. The exact text of the proposed changes is not included in the provided summary. A companion House bill is HF 3195.

What the bill would do (as indicated by the title)

  • The bill seeks to modify current limitations on optometrists’ ability to prescribe medications and administer drugs.
  • Specific provisions (e.g., which drugs, prescribing conditions, administration methods, supervision requirements, or patient-safety safeguards) are not detailed in the provided materials. For precise changes, the bill language or committee analysis from SF 1499 and HF 3195 should be consulted.

Status and timeline

  • Introduced: February 17, 2025
  • First reading and referred to: Health and Human Services (February 17, 2025)
  • Legislative actions:
    • February 27, 2025: Author changed to Abeler
    • March 27, 2025: Author stricken (Koran)
  • Companion bill: HF 3195 (House of Representatives version)

Who would be affected

  • Optometrists: Likely changes to scope of practice related to drug prescribing and administration.
  • Patients: Potential changes in access to medications prescribed or administered by optometrists, depending on the final provisions.
  • Other health professionals (e.g., ophthalmologists, physicians): Possible shifts in referral patterns or collaboration requirements if scope changes affect treatment pathways.
  • Health systems, clinics, and insurers: Impacts on prescribing workflows, reimbursement, and formulary considerations if optometrists gain or alter prescribing authority.

Procedural and timeline considerations

  • The bill is currently in the Health and Human Services policy area, with a companion in the House (HF 3195) to parallel the Senate proposal.
  • With the author changes noted (Abeler, then stricken author list), the bill may undergo further amendments or reintroduction of authors.
  • To understand the full path forward, monitor:
    • Text of SF 1499 and any amendments
    • HF 3195 text and amendments
    • Committee hearings and fiscal notes
    • Any changes to scope, safety requirements, or prescribing protocols

Additional notes

  • The provided information does not include the bill’s exact language, effective dates, implementation timelines, or funding implications. For a complete understanding, review the official bill texts, fiscal impact statements, and committee materials on the Minnesota Legislature website.
  • Related materials and analyses may be available by comparing SF 1499 with its companion HF 3195.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.